Allergies & Asthma

Short-term treatment with a low-dose opioid was associated with significantly improved health status in chronic obstructive pulmonary disease (COPD) patients with advanced disease and chronic breathlessness despite optimal pharmaceutical and non-pharmaceutical treatment. In a randomized trial of over 100 patients, twice daily treatment for 4 weeks with an oral sustained-release morphine (10 mg) was associated
0 Comments
Choosing a college or university to attend for ‘the best years of your life’ can seem overwhelming and intimidating. Moving far from family and living with strangers in a completely new environment can be especially daunting when paired with a severe food allergy. In this blog, find tips to help navigate visiting and deciding on
0 Comments
As another so-called triple therapy for chronic obstructive pulmonary disease (COPD) hits the market, pulmonologists and primary care physicians are beginning to consider which patients are most appropriate for these treatments, and how much added benefit these products offer relative to more conventional — and better understood — two-drug combinations. The FDA approved AstraZeneca’s fixed-dose,
0 Comments
Throughout the spring, summer, and fall, your favorite weather source may share pollen counts for your area. These counts are used as a warning for those with environmental allergies – explaining what’s in the air and the level of symptoms you can expect. Without a little research, these pollen counts can seem confusing, but it
0 Comments
Inhaled triple therapy with budesonide, glycopyrrolate, and formoterol showed a signal of reducing all-cause mortality in patients with moderate to severe chronic obstructive pulmonary disease (COPD) at higher (320 μg) budesonide doses in newly reported findings from the large, multicenter, 52-week ETHOS trial. Two doses of the glucocorticoid — 160 μg and 320 μg —
0 Comments
The development of a subtype of inflammatory myopathy characterized by interstitial lung disease and positivity for a specific autoantibody was influenced by seasonality and place of residence, Japanese researchers found. Among patients with polymyositis or dermatomyositis (PM/DM) and the associated interstitial lung disease, symptom onset occurred most often from October to March for those with
0 Comments
WASHINGTON — The FDA approved the first generic version of the Proventil HFA albuterol inhaler, citing increased demand for this type of product as a treatment for COVID-19. The metered dose inhaler, made by Cipla Ltd., delivers 90 μg albuterol sulfate per puff; the approved indication is for “treatment or prevention of bronchospasm in patients
0 Comments
earn free cme credit Earn CME credit by reading this article and completing the posttest. Sign Up Study Authors: Peter K. Lindenauer, Mihaela S. Stefan, et al.; Carolyn L. Rochester, Anne E. Holland Target Audience and Goal Statement: Pulmonologists, hospitalists The goal of this study was to determine the association between initiation of pulmonary rehabilitation
0 Comments
Cancer, diabetes, heart disease and musculoskeletal issues are often the conditions employers are most eager to tackle, and we don’t blame them – these are conditions that cost employers billions of dollars year after year. But many times, employers crunch the numbers, come up with preventive measures, and they’re still not seeing the decrease in
0 Comments
If you, like the Skeptical Cardiologist, suffer from asthma you may be wondering if you are at a higher risk of contracting COVID-19 or developing more severe respiratory complications from the disease once infected. There are 25 million asthma sufferers in the United States, about 8% of the population, and many of us are using
0 Comments
Pulmonary rehabilitation within 3 months of hospital discharge was associated with a significant reduction in deaths at 1 year in a study involving 197,376 Medicare beneficiaries hospitalized for chronic obstructive pulmonary disease (COPD) exacerbations. Peter Lindenauer, MD, of the University of Massachusetts Medical School in Springfield, and co-researchers reported that fewer than 2% of patients
0 Comments
Exposure to synthetic endocrine-disrupting chemicals found in pesticides, nonstick cookware, and fire retardants was linked to increased risk for celiac disease in children and young adults in a small observational study. Overall, young people with higher serum concentrations of dichlorodiphenyldichloroethylene (DDE) had twice the risk for developing celiac disease (OR 2.01, 95% CI 1.07-3.78) after
0 Comments
This is the sixth story in a series by MedPage Today examining the impact of COVID-19 on vulnerable populations. Past stories reported on the homeless, immigrants in detention, the undocumented, nursing home residents, and incarcerated individuals. With limited national data available to track COVID-19 outcomes by race, states and local municipalities started releasing their own
0 Comments